DYSPNOEA is the #8 most commonly reported adverse reaction for ACETAMINOPHEN 500MG, manufactured by Allegiant Health. There are 14,183 FDA adverse event reports linking ACETAMINOPHEN 500MG to DYSPNOEA. This represents approximately 1.9% of all 734,137 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 500MG who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DYSPNOEA14,183 of 734,137 reports
DYSPNOEA is a less commonly reported adverse event for ACETAMINOPHEN 500MG, but still significant enough to appear in the safety profile.
Other Side Effects of ACETAMINOPHEN 500MG
In addition to dyspnoea, the following adverse reactions have been reported for ACETAMINOPHEN 500MG:
DYSPNOEA has been reported as an adverse event in 14,183 FDA reports for ACETAMINOPHEN 500MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DYSPNOEA with ACETAMINOPHEN 500MG?
DYSPNOEA accounts for approximately 1.9% of all adverse event reports for ACETAMINOPHEN 500MG, making it a notable side effect.
What should I do if I experience DYSPNOEA while taking ACETAMINOPHEN 500MG?
If you experience dyspnoea while taking ACETAMINOPHEN 500MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.